3-chloro-L-tyrosine has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, RV; Chua, J; Fritsche-Danielson, R; Gan, LM; Hausenloy, DJ; Hernandez-Resendiz, S; Jonsson, MKB; Knöll, R; Kp, MMJ; Liehn, EA; Lin, YH; Michaëlsson, E; Ramachandra, CJA; Ryden-Markinhuhta, K; Sadayappan, S; Shim, W; Tang, HC; Wong, P | 1 |
1 other study(ies) available for 3-chloro-L-tyrosine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
Topics: Animals; Cardiac Myosins; Cardiomyopathy, Hypertrophic; Carrier Proteins; Cell Line; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertrophy, Left Ventricular; Induced Pluripotent Stem Cells; Male; Mice, Inbred C57BL; Mutation, Missense; Myocardial Contraction; Myocytes, Cardiac; Myosin Heavy Chains; Peroxidase; Phosphorylation; Reactive Oxygen Species; Tyrosine; Ventricular Function, Left | 2022 |